Vicore Pharma

Vicore Pharma

Sweden - Stockholm
Pharmaceutical1 H-1B visas (FY2023)

Focus: Small Molecule

Vicore Pharma is a life sciences company focused on Small Molecule.

RespiratoryInfectious DiseasesMetabolic Diseases
Funding Stage
PUBLIC
Open Jobs
0

Pipeline & Clinical Trials

Digital cognitive behavioral therapy
Pulmonary Fibrosis
N/A
Clinical Trials (1)
NCT05330312Controlled Investigation to Evaluate Impact of dCBT on Psychological Symptom Burden in Adult Subjects With PF
N/A
N/A
Clinical Trials (1)
NCT04878913Retrospective Evaluation of Lung Pathology in Subjects With COVID-19
N/A
Drug Drug Interaction
Drug Interaction
Phase 1
Clinical Trials (1)
NCT05830799A Trial to Evaluate the Impact of C21 on the Exposure of 4 Substrates in Healthy Volunteers
Phase 1
Phase 1
Clinical Trials (1)
NCT05831644A Trial to Evaluate the Effect of C21 on Endothelial Dysfunction in Subjects With Type 2 Diabetes
Phase 1
C106 solution
Safety Issues
Phase 1
Clinical Trials (1)
NCT05427253First-in-human Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of C106 in Healthy Subjects
Phase 1
Clinical Trials (1)
NCT05277922Effect of C21 on Forearm Blood Flow
Phase 1
Clinical Trials (1)
NCT06588686A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis.
Phase 2
Clinical Trials (1)
NCT04533022Safety, Efficacy and Pharmacokinetics of C21 in Subjects With IPF
Phase 2
Clinical Trials (1)
NCT04388176Cold Challenge With C21 in RP
Phase 2
Phase 2
Clinical Trials (1)
NCT04452435Safety and Efficacy of C21 in Subjects With COVID-19
Phase 2
Phase 3
Clinical Trials (1)
NCT04880642A Trial to Investigate Recovery From COVID-19 With C21 in Adult Subjects
Phase 3

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts
Portfolio: 11 clinical trials
Top TAs: Respiratory, Infectious Diseases, Cardiovascular
H-1B (2023): 1 approval
Publications: 8 in PubMed
Therapeutic Area Focus
Respiratory
4 pipeline
Cardiovascular
1 pipeline
Neurology
1 pipeline
Marketed
Pipeline

Visa Sponsorship

Sponsors Work Visas
H-1B Petitions (FY2023)
1
Approved
0
Denied
100%
Rate

Source: USCIS H-1B Employer Data Hub